Law ❯ Litigation ❯ Securities Litigation

False Statements

Investor Claims Market Misleading Practices Material Misrepresentation Misleading Information Market Misrepresentation Investor Compensation Legal Representation Investor Protection Investor Loss Recovery Material Omissions Regulatory Compliance Misleading Statements Snowflake Inc. False Statements Shareholder Rights Clinical Trials Investor Damages Market Manipulation

Multiple Firms Race to Lead Securities Suit Against ARS Pharmaceuticals

The October 5 lead‑plaintiff deadline will determine who controls discovery, damages claims, settlement strategy.

Securities Suit Targets Cogent Over Alleged Illusory Wavelength Backlog

Investors File Securities Class Action Against PROCEPT BioRobotics

Investors File Class Action Over Alleged Founder‑Linked Deals at EquipmentShare

Securities Suit Alleges Badger Meter Pulled Forward Orders to Inflate Revenue

Law Firms Rally BellRing Investors Ahead of Lead‑Plaintiff Deadline in Securities Case

Law Firms Urge CoreWeave Investors to Seek Lead Role in Securities Class Action Before March 13

Inspire Medical Investors Face Jan. 5 Deadline in Suit Over Inspire V Rollout Claims

Law Firms Press Primo Brands Investors to Join Securities Suits Ahead of Jan. 12 Lead‑Plaintiff Deadline

Inspire Medical Investors Urged to Act as Jan. 5 Lead‑Plaintiff Deadline Nears in Inspire V Securities Case

Inspire Medical Securities Case Enters Lead-Plaintiff Phase Ahead of Jan. 5 Deadline

Telix Sued by Investors Over Prostate Therapy Claims After SEC Subpoena and FDA Rejection